165 related articles for article (PubMed ID: 36075579)
1. Preoperative CA125 as a risk factor for symptom recurrence of adenomyosis after ultrasound-guided high-intensity focused ultrasound ablation surgery.
Tang Y; Ming-Tao Y; Xiang RM; Xu W; Zhang RY; Weng MB; Tang FX; Hu HQ; Xu F; Li J; Shi Q
Int J Hyperthermia; 2022; 39(1):1164-1169. PubMed ID: 36075579
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging-Based Classification Systems for Informing Better Outcomes of Adenomyosis After Ultrasound-Guided High-Intensity Focused Ultrasound Ablating Surgery.
Tang Y; Hu WH; Wang H; Wu J; Wen MB; Su B; Jiang ZJ; Jiang X; Zhu LJ; Ding N; Yang MT; Yin S; Hu HQ; Xu F; Li J; Shi Q
J Magn Reson Imaging; 2024 May; 59(5):1787-1797. PubMed ID: 37671487
[TBL] [Abstract][Full Text] [Related]
3. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
Guo Y; Duan H; Cheng J; Zhang Y
BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
[TBL] [Abstract][Full Text] [Related]
4. Analysis of related factors influencing postoperative recurrence of adenomyosis treated with HIFU.
Fan LX; Zhang Y; Yang LL; Ji XL; Wang Y; Huang YF; Shi L; Wen Y
Arch Gynecol Obstet; 2024 May; 309(5):1765-1773. PubMed ID: 38347252
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy of focused ultrasound ablation surgery in the treatment of internal adenomyosis].
Xiao X; Gong CM; Zhang R; Zhang L; Wang ZB
Zhonghua Fu Chan Ke Za Zhi; 2022 Apr; 57(4):259-264. PubMed ID: 35484657
[No Abstract] [Full Text] [Related]
6. Serum CA125 as a biomarker for dysmenorrhea in adenomyosis.
Tang Y; Wen MB; Xiang RM; Yang MT; Shu B; Xu F; Li J; Hu HQ; Shi Q
Int J Gynaecol Obstet; 2023 Oct; 163(1):131-139. PubMed ID: 37177806
[TBL] [Abstract][Full Text] [Related]
7. Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound.
Zhang X; Li K; Xie B; He M; He J; Zhang L
Int J Gynaecol Obstet; 2014 Mar; 124(3):207-11. PubMed ID: 24380611
[TBL] [Abstract][Full Text] [Related]
8. [Pregnancy outcomes and symptom improvement of patients with adenomyosis treated with high intensity focused ultrasound ablation].
Zhou CY; Xu XJ; He J
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):845-849. PubMed ID: 27916069
[No Abstract] [Full Text] [Related]
9. Transcervical Ultrasound-guided Radiofrequency Ablation of Adenomyosis: A Case Report.
Goldrath KE; Parvataneni R; Munro MG; Mehta SK
J Minim Invasive Gynecol; 2023 Jun; 30(6):502-507. PubMed ID: 36878403
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Ultrasound-Guided High-Intensity Focused Ultrasound Treatment for Uterine Fibroids and Adenomyosis.
Lee JS; Hong GY; Lee KH; Song JH; Kim TE
Ultrasound Med Biol; 2019 Dec; 45(12):3214-3221. PubMed ID: 31563479
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study.
Gong C; Yang B; Shi Y; Liu Z; Wan L; Zhang H; Jiang D; Zhang L
Int J Hyperthermia; 2016 Aug; 32(5):496-503. PubMed ID: 27385316
[TBL] [Abstract][Full Text] [Related]
12. The role of T1 perfusion-based classification in predicting the outcome of magnetic resonance-guided high-intensity focused ultrasound treatment of adenomyosis.
Keserci B; Duc NM
Int J Hyperthermia; 2018 May; 34(3):306-314. PubMed ID: 28540825
[TBL] [Abstract][Full Text] [Related]
13. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility.
Zhang L; Rao F; Setzen R
Acta Obstet Gynecol Scand; 2017 Jun; 96(6):707-714. PubMed ID: 28437003
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: A single center experience from the Republic of Korea.
Lee JS; Hong GY; Park BJ; Kim TE
Ultrason Sonochem; 2015 Nov; 27():682-687. PubMed ID: 26072367
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Transabdominal Ultrasound-guided Percutaneous Microwave Ablation in the Treatment of Symptomatic Adenomyosis: A Retrospective Cohort Study.
Li S; Li Z; Lin M; Li X; Gao L; Qiu J; He J; Zhang J; Lyu G
J Minim Invasive Gynecol; 2023 Feb; 30(2):137-146. PubMed ID: 36384213
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis.
Pang LL; Mei J; Fan LX; Zhao TT; Li RN; Wen Y
Front Public Health; 2021; 9():688264. PubMed ID: 34485218
[No Abstract] [Full Text] [Related]
17. Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis: A Retrospective Study.
Liu X; Wang W; Wang Y; Wang Y; Li Q; Tang J
Medicine (Baltimore); 2016 Jan; 95(3):e2443. PubMed ID: 26817877
[TBL] [Abstract][Full Text] [Related]
18. Comparison efficacy of ultrasound-guided HIFU for adenomyosis-associated dysmenorrhea with different signal intensity on T2-weighted MR imaging.
Yu J; Jiang L; Su X; Yang M; Yang C; Chen J
J Obstet Gynaecol Res; 2023 Apr; 49(4):1189-1197. PubMed ID: 36733261
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of high intensity focused ultrasound treatment for different types of adenomyosis based on magnetic resonance imaging classification.
Gong C; Wang Y; Lv F; Zhang L; Wang Z
Int J Hyperthermia; 2022; 39(1):530-538. PubMed ID: 35300545
[TBL] [Abstract][Full Text] [Related]
20. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
Lee JS; Hong GY; Lee KH; Kim TE
BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
